ClinVar Miner

Submissions for variant NM_000214.3(JAG1):c.388-4G>C

gnomAD frequency: 0.00002  dbSNP: rs567027490
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000389399 SCV000432949 benign Isolated Nonsyndromic Congenital Heart Disease 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV001088224 SCV000645531 benign Alagille syndrome due to a JAG1 point mutation 2024-01-11 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000728129 SCV000855663 benign not specified 2017-07-10 criteria provided, single submitter clinical testing
GeneDx RCV000840668 SCV000982596 likely benign not provided 2019-10-07 criteria provided, single submitter clinical testing
Ambry Genetics RCV002356471 SCV002620572 likely benign Cardiovascular phenotype 2018-01-15 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Fulgent Genetics, Fulgent Genetics RCV002502301 SCV002811412 benign Alagille syndrome due to a JAG1 point mutation; Tetralogy of Fallot; Deafness, congenital heart defects, and posterior embryotoxon; Charcot-Marie-Tooth disease, axonal, Type 2HH 2021-10-20 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000840668 SCV004149888 likely benign not provided 2023-05-01 criteria provided, single submitter clinical testing JAG1: BP4, BS1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.